Congenital distal spinal muscular atrophy

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Congenital distal spinal muscular atrophy
Denervation atrophy
Synonyms	Distal hereditary motor neuropathy, Type 1
Pronounce	N/A
Specialty	Neurology
Symptoms	Muscle weakness, muscle atrophy, distal limb involvement
Complications	N/A
Onset	Congenital
Duration	Lifelong
Types	N/A
Causes	Genetic mutations
Risks	Family history
Diagnosis	Genetic testing, Electromyography, Nerve conduction study
Differential diagnosis	Spinal muscular atrophy, Charcot-Marie-Tooth disease
Prevention	N/A
Treatment	Physical therapy, Occupational therapy, Orthopedic surgery
Medication	N/A
Prognosis	Variable, generally stable
Frequency	Rare
Deaths	N/A

Congenital Distal Spinal Muscular Atrophy (CDSMA) is a rare neuromuscular disorder characterized by progressive muscle weakness and atrophy. It is a subtype of Spinal Muscular Atrophy (SMA), a group of hereditary diseases that cause weakness and wasting of the voluntary muscles in the arms and legs of infants and children.

Etiology

CDSMA is caused by mutations in the TRPV4 gene. This gene provides instructions for making a protein that is involved in various cellular functions, including the regulation of ion channels. Mutations in the TRPV4 gene disrupt the function of the protein, leading to the death of nerve cells in the spinal cord that control muscle movement.

Clinical Features

The symptoms of CDSMA typically appear at birth or in early infancy. They include weakness and wasting (atrophy) of the muscles of the lower limbs (distal muscles), particularly the muscles of the feet and hands. As the disease progresses, the weakness and atrophy may spread to other muscles of the body. Other features may include joint deformities (contractures), abnormalities of the spine (scoliosis), and respiratory problems.

Diagnosis

The diagnosis of CDSMA is based on the clinical symptoms, a detailed patient history, and specialized tests. These tests may include a nerve conduction study (NCS), electromyography (EMG), and genetic testing to identify mutations in the TRPV4 gene.

Treatment

There is currently no cure for CDSMA. Treatment is supportive and aims to improve the quality of life for individuals with the disorder. This may include physical therapy, occupational therapy, and the use of assistive devices to help with mobility. In some cases, surgery may be necessary to manage complications such as scoliosis.

Prognosis

The prognosis for individuals with CDSMA varies. Some individuals may have a normal life expectancy, while others may experience severe complications that can be life-threatening.

See Also

• Spinal Muscular Atrophy
• TRPV4
• Neuromuscular disorder
• Genetic disorder